AU2001289849A1 - Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate - Google Patents

Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate

Info

Publication number
AU2001289849A1
AU2001289849A1 AU2001289849A AU8984901A AU2001289849A1 AU 2001289849 A1 AU2001289849 A1 AU 2001289849A1 AU 2001289849 A AU2001289849 A AU 2001289849A AU 8984901 A AU8984901 A AU 8984901A AU 2001289849 A1 AU2001289849 A1 AU 2001289849A1
Authority
AU
Australia
Prior art keywords
carnitine
granulated
preparing
mixture
magnesium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001289849A
Other languages
English (en)
Inventor
Martin Fuhrmann
Daniel Pianzola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Publication of AU2001289849A1 publication Critical patent/AU2001289849A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001289849A 2000-08-29 2001-08-29 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate Abandoned AU2001289849A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00118656.8 2000-08-29
EP00118656 2000-08-29
PCT/EP2001/009962 WO2002017735A2 (de) 2000-08-29 2001-08-29 Verfahren zur herstellung einer granulierbaren mischung und carnitin-magnesium-hydroxycitrat

Publications (1)

Publication Number Publication Date
AU2001289849A1 true AU2001289849A1 (en) 2002-03-13

Family

ID=8169680

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001289849A Abandoned AU2001289849A1 (en) 2000-08-29 2001-08-29 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate

Country Status (10)

Country Link
US (2) US20030176514A1 (de)
EP (1) EP1326502B1 (de)
JP (1) JP4668513B2 (de)
AT (1) ATE295690T1 (de)
AU (1) AU2001289849A1 (de)
DE (1) DE50106272D1 (de)
DK (1) DK1326502T3 (de)
ES (1) ES2242770T3 (de)
PT (1) PT1326502E (de)
WO (1) WO2002017735A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20030831A1 (it) 2003-04-22 2004-10-23 Laboratorio Chimico Int Spa Sale basico dell'acido tiottico con la l-carnitina.
JP2007505129A (ja) * 2003-09-11 2007-03-08 グリュコン テクノロジーズ グループ エルエルシー （−）−ヒドロキシクエン酸の腸溶性送達物
EP1734974A1 (de) * 2004-03-18 2006-12-27 Tanabe Seiyaku Co., Ltd. D-ribose zur verbesserung von depressionsartigen symptomen
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
AU2006265280B2 (en) 2005-07-05 2011-07-14 Lonza Ag Spray-drying process for producing a dry carnitine powder or granulate
US20070072910A1 (en) * 2005-09-29 2007-03-29 Smith Michael L Compositions and methods for lowering plasma concentrations of low density lipoproteins in humans
EP1968564B1 (de) * 2005-12-19 2015-09-16 Abbott Laboratories Verwendung von beta-hydroxy-beta-methylbuttersaeure zur modulierung eines fehlverhaeltnisses der typ 1- und typ 2-zytokinproduktion
CN101209975B (zh) * 2006-12-29 2010-12-01 沈阳科硕营养科技有限公司 左旋肉碱富马酸钙及其制备方法与用途
EP2206440A1 (de) * 2008-12-24 2010-07-14 Taminco Verfahren zum Herstellen eines rieselfähigen Pulvers, das eine zerfließende quartäre Ammoniumverbindung enthält
PE20121730A1 (es) 2010-01-29 2013-01-13 Abbott Lab Liquidos nutricionales envasados asepticamente que comprenden beta-hidroxi-beta-metilbutirato (hmb)
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
CN102711524B (zh) 2010-01-29 2014-09-10 雅培制药有限公司 包含hmb钙的营养乳剂
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153640A (en) * 1967-04-10 1969-05-29 Soc D Etudes Prod Chimique A Carnitin Salt
DE3463261D1 (en) * 1983-12-28 1987-05-27 Sigma Tau Ind Farmaceuti Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
IT1172394B (it) * 1983-12-28 1987-06-18 Sigma Tau Ind Farmaceuti Sali della l-carnitina e di alcuni alcanoil derivati della l-carnitina e procedimento per la loro preparazione
CA2018137C (en) * 1989-06-14 2000-01-11 Thomas Scholl L-carnitine magnesium citrate
US5780451A (en) * 1994-04-01 1998-07-14 Abbott Laboratories Nutritional product for a person having ulcerative colitis
WO1996036585A1 (en) * 1995-05-15 1996-11-21 Sabinsa Corporation A new process for the production of potassium hydroxy citric acid, and compositions containing the potassium hydroxy citric acid
IT1276253B1 (it) * 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
US5817329A (en) * 1997-02-28 1998-10-06 Gardiner; Paul T. Nutritional supplement for increased muscle size and strength for body builders
IT1291134B1 (it) * 1997-04-08 1998-12-29 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato
IT1290600B1 (it) * 1997-04-30 1998-12-10 Sigma Tau Ind Farmaceuti Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato

Also Published As

Publication number Publication date
US20040167219A1 (en) 2004-08-26
ATE295690T1 (de) 2005-06-15
WO2002017735A2 (de) 2002-03-07
ES2242770T3 (es) 2005-11-16
JP4668513B2 (ja) 2011-04-13
EP1326502B1 (de) 2005-05-18
PT1326502E (pt) 2005-09-30
WO2002017735A3 (de) 2002-09-12
EP1326502A2 (de) 2003-07-16
US20030176514A1 (en) 2003-09-18
US7230131B2 (en) 2007-06-12
DK1326502T3 (da) 2005-08-22
DE50106272D1 (de) 2005-06-23
JP2004507479A (ja) 2004-03-11

Similar Documents

Publication Publication Date Title
HUP0100823A3 (en) Hydrotalcite compound, process for producing the same, and agricultural film containing the same
HK1086296A1 (en) Process for producing dipeptide
HUP0003305A3 (en) Hiv protease inhibiting tetrahydro-pyrimid-2-on derivative, pharmaceutical compositions containing it and process for producing the compound
AU4048299A (en) Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
AU2001289849A1 (en) Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
WO2002053516A3 (fr) Derives de la n(phenylsulfonyl)glycine et leur utilisation en therapeutique
MXPA02006826A (es) Un inhibidor de division celular y un metodo de produccion del mismo.
ZA200105394B (en) Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them.
AP1703A (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
HK1054026A1 (en) Substituted piperidines, medicaments containing these compounds, and methods for the production thereof.
AU3824599A (en) Method for producing (s,s)-benzyl-2,8-diazabicyclo{4.3.0}nonane
AU4652499A (en) Pyrazole-type compounds, process for producing the same and herbicides containing the same
MY141607A (en) Lactam compound
ZA200007253B (en) Process for preparing 1,4-dihydropyridine compounds.
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
IL156141A0 (en) A process for the preparation of taxan derivatives
AU5585700A (en) Process for making 2,4,6, 8,10,12- hexanitro- 2,4,6,8,10, 12- hexa azatetracyclo(5.5.0. 05,9.03,11} -dodecane
AU5419699A (en) Methoximinophenylacetic acid amides
ZA200103065B (en) Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them.
AU1798200A (en) Process for producing l-erythro-(1r,2s)-2-amino-1-phenylpropan-1-ol
AU1983400A (en) Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same
ZA200103064B (en) Cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them.
AU2002254887A1 (en) Process for the carbonylation of ethylenically unsaturated compounds, bidentate diphosphine composition used in this process and processes for preparation of this bidentate diphosphine composition
AU2001234795A1 (en) Process for obtaining 1, 2, 3, 5, 6, 7, 8, 8a-oltahydro-1, 2, 8, 8tetramethylnaphthalen-2-yl!etan-1-one
MXPA03008636A (es) Derivados de isoquinuclidina, metodo para fabricar los mismos y agentes terapeuticos que contienen estos compuestos.